These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 37962954)
21. Silencing circ_0074371 inhibits the progression of sepsis-induced acute kidney injury by regulating miR-330-5p/ELK1 axis. Wang QY; Zhang RR; Cui L; Sun YP Mamm Genome; 2022 Dec; 33(4):642-653. PubMed ID: 35994105 [TBL] [Abstract][Full Text] [Related]
22. Circ_0038467 regulates lipopolysaccharide-mediated cell proliferation, apoptosis, and inflammatory response by miR-195-5p/TLR4 axis through NF-κB pathway in MRC-5 cells. Zheng Y; Wang Y; Zhu X; Diao Y; Chen Y; Chen G Biosci Biotechnol Biochem; 2021 Jun; 85(7):1639-1649. PubMed ID: 34021567 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of circ-ZNF644 alleviates LPS-induced HK2 cell injury via miR-335-5p/HIPK1 axis. Gong J; Zhao S; Luo S; Yin S; Li X; Feng Y Environ Toxicol; 2022 Dec; 37(12):2855-2864. PubMed ID: 36052886 [TBL] [Abstract][Full Text] [Related]
24. Circ_0091702 serves as a sponge of miR-545-3p to attenuate sepsis-related acute kidney injury by upregulating THBS2. Tan M; Bei R J Mol Histol; 2021 Aug; 52(4):717-728. PubMed ID: 34101064 [TBL] [Abstract][Full Text] [Related]
25. Knockdown of circ-UQCRC2 ameliorated lipopolysaccharide-induced injury in MRC-5 cells by the miR-326/PDCD4/NF-κB pathway. Zhou G; Duan Y; Lu C; Wang W Int Immunopharmacol; 2021 Aug; 97():107633. PubMed ID: 33895481 [TBL] [Abstract][Full Text] [Related]
26. CIRC_0114428 INFLUENCES THE PROGRESSION OF SEPTIC ACUTE KIDNEY INJURY VIA REGULATING MIR-370-3P/TIMP2 AXIS. Zhang B; You T; Liu Y; Li P Shock; 2023 Mar; 59(3):505-513. PubMed ID: 36597773 [TBL] [Abstract][Full Text] [Related]
27. Circ_0114428 Regulates Sepsis-Induced Kidney Injury by Targeting the miR-495-3p/CRBN Axis. He Y; Sun Y; Peng J Inflammation; 2021 Aug; 44(4):1464-1477. PubMed ID: 33830389 [TBL] [Abstract][Full Text] [Related]
28. CIRC_0012535 CONTRIBUTES TO LIPOPOLYSACCHARIDE-INDUCED FETAL LUNG FIBROBLAST APOPTOSIS AND INFLAMMATION TO REGULATE INFANTILE PNEUMONIA DEVELOPMENT BY MODULATING THE MIR-338-3P/IL6R SIGNALING. Fang X; Mei W; Zeng R; Zou L; Zeng X; Tang S Shock; 2023 May; 59(5):820-828. PubMed ID: 36870073 [TBL] [Abstract][Full Text] [Related]
29. Circ-BICC1 Knockdown Alleviates Lipopolysaccharide (LPS)-Induced WI-38 Cell Injury Through miR-338-3p/MYD88 Axis. Wang J; Li G; Lin S; Cheng L Biochem Genet; 2023 Feb; 61(1):170-186. PubMed ID: 35809112 [TBL] [Abstract][Full Text] [Related]
30. A novel circular RNA (hsa_circ_0059930)-mediated miRNA-mRNA axis in the lipopolysaccharide-induced acute lung injury model of MRC-5 cells. Han J; Li S; Feng Y; He Y; Hong W; Ye Z Bioengineered; 2021 Dec; 12(1):1739-1751. PubMed ID: 34002668 [TBL] [Abstract][Full Text] [Related]
31. CIRCKLHL2 KNOCKDOWN ALLEVIATES SEPSIS-INDUCED ACUTE LUNG INJURY BY REGULATING MIR-29B-3P MEDIATED ROCK1 EXPRESSION DOWN-REGULATION. Li N; Li Y; Wu B; Sun R; Zhao M; Hu Z Shock; 2023 Jan; 59(1):99-107. PubMed ID: 36476974 [TBL] [Abstract][Full Text] [Related]
32. Circ_0038467 regulates lipopolysaccharide-induced inflammatory injury in human bronchial epithelial cells through sponging miR-338-3p. Liu G; Wan Q; Li J; Hu X; Gu X; Xu S Thorac Cancer; 2020 May; 11(5):1297-1308. PubMed ID: 32181994 [TBL] [Abstract][Full Text] [Related]
33. Knockdown of circ_0038467 alleviates lipopolysaccharides-induced 16HBE cell injury by regulating the miR-545-3p/TRAF1 axis in neonatal pneumonia. Xia F; Yang L; Zhu X Microb Pathog; 2022 Dec; 173(Pt A):105819. PubMed ID: 36216207 [TBL] [Abstract][Full Text] [Related]
34. CIRC_0002131 CONTRIBUTES TO LPS-INDUCED APOPTOSIS, INFLAMMATION, AND OXIDATIVE INJURY IN HK-2 CELLS VIA INHIBITING THE BINDING BETWEEN MIR-942-5P AND OXSR1. Zhang P; Yin J; Xun L; Ding T; Du S Shock; 2023 Oct; 60(4):517-524. PubMed ID: 37549022 [TBL] [Abstract][Full Text] [Related]
35. CircWDR33 alleviates human pulmonary microvascular endothelial cell injury in sepsis-associated acute lung injury by targeting miR-217-5p/SERP1 axis. You T; Zhang B Int Immunopharmacol; 2022 Dec; 113(Pt B):109440. PubMed ID: 36417821 [TBL] [Abstract][Full Text] [Related]